Skip to content

Evolution of Facial Trauma During COVID Containment Measures

Evolution of Maxillofacial Trauma Activity During COVID-19 Containment Measures: a French Multicentric Comparative Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04355442
Acronym
Traumax
Enrollment
300
Registered
2020-04-21
Start date
2020-04-01
Completion date
2020-05-30
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Maxillofacial Injuries, Skull Fractures

Keywords

Pandemics, Maxillofacial fractures, Facial trauma, Containment, Quarenteen, Outbreak

Brief summary

The COVID-19 global pandemic has led to a major professional and social national reorganization: professional because it involves a redeployment of medical staff and material resources, and social because it imposes prolonged containment measures on an entire population. The maxillofacial trauma activity is mainly linked to sports or leisure accidents, fights and road accidents. It seems to appear since the beginning of containment measures a significant drop in maxillofacial trauma activity at the national level, which, if it is demonstrated in a significant way in several French hospital centers, would allow to redeploy the material and human resources related to this activity on sectors in tension due to the pandemic.

Detailed description

This study will compare maxillo-facial activity during the first month of COVID-19 containment measures in France with a comparable period in 2018 and 2019. This comparison will be made in 10 major French hospital centers.

Interventions

PROCEDUREFacial fractures reduction or osteosynthesis

Facial fractures reduction or osteosynthesis

Sponsors

Unités de CMF des CHU de Paris (Dr Davrou - Pitié salpetrière)
CollaboratorUNKNOWN
Amiens (Dr Dapke)
CollaboratorUNKNOWN
Nantes (Pr Corre)
CollaboratorUNKNOWN
Toulouse (Pr Lauwers - Purpan)
CollaboratorUNKNOWN
Marseille (Dr Foletti - La conception)
CollaboratorUNKNOWN
Nice (Dr Savoldelli)
CollaboratorUNKNOWN
Clermont Ferrand (Dr Sesque)
CollaboratorUNKNOWN
Perpignan (Dr Llobet)
CollaboratorUNKNOWN
Lyon (Dr Bourlet - Croix Rousse)
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Maxillo-facial fracture * Requiring * Trauma that occured between March 16 and April 15, 2020 or 2018 or 2019 * All ages

Exclusion criteria

* Patients who refused the collection of their data

Design outcomes

Primary

MeasureTime frameDescription
evolution of number of maxillofacial trauma1 yearevolution of number of maxillofacial trauma during COVID-19 first month of containment measures compared to the same period in 2018 and 2019.the number of patients from different investigator centers operated for a facial fracture occurring between March 16, 2020 and April 15, 2020 will be compared to the number of patients in these same centers operated for a facial fracture during the same period in 2018 and in 2019. A sub-group analysis, by center, will also be carried out.

Secondary

MeasureTime frameDescription
variability in terms of type of trauma1 yearstudy of variability in terms of type of trauma with and without confinement.
Comparative assessment of types of trauma by the inter-regional variability1 yearComparative assessment of types of trauma by the inter-regional variability : study of the inter-regional variability of maxillofacial trauma

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026